[go: up one dir, main page]

EP1251955A2 - Matrice de biopuces, haute densite, adressable par colonnes et rangees - Google Patents

Matrice de biopuces, haute densite, adressable par colonnes et rangees

Info

Publication number
EP1251955A2
EP1251955A2 EP00984476A EP00984476A EP1251955A2 EP 1251955 A2 EP1251955 A2 EP 1251955A2 EP 00984476 A EP00984476 A EP 00984476A EP 00984476 A EP00984476 A EP 00984476A EP 1251955 A2 EP1251955 A2 EP 1251955A2
Authority
EP
European Patent Office
Prior art keywords
conductive electrode
electrode layer
probes
conductive
target molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00984476A
Other languages
German (de)
English (en)
Inventor
Song Shi
Peiming Zhang
George N. Maracas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Motorola Solutions Inc
Original Assignee
Motorola Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Motorola Inc filed Critical Motorola Inc
Publication of EP1251955A2 publication Critical patent/EP1251955A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
    • G01N27/3276—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction being a hybridisation with immobilised receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438—Electrodes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00279—Features relating to reactor vessels
    • B01J2219/00306—Reactor vessels in a multiple arrangement
    • B01J2219/00313—Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
    • B01J2219/00315—Microtiter plates
    • B01J2219/00317—Microwell devices, i.e. having large numbers of wells
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B01J2219/00511—Walls of reactor vessels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00653—Making arrays on substantially continuous surfaces the compounds being bound to electrodes embedded in or on the solid supports
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00659—Two-dimensional arrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00677—Ex-situ synthesis followed by deposition on the substrate
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068—Means for controlling the apparatus of the process
    • B01J2219/00698—Measurement and control of process parameters
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068—Means for controlling the apparatus of the process
    • B01J2219/00702—Processes involving means for analysing and characterising the products
    • B01J2219/00704—Processes involving means for analysing and characterising the products integrated with the reactor apparatus
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds

Definitions

  • This invention relates to the detection of biomolecules. Specifically, the invention relates to electronic or electrochemical detection of biomolecules using biochip arrays. In particular, the invention provides an apparatus comprising a platform for a column-and- row addressable, high-density, enhanced-sensitivity biochip array, and methods of use thereof.
  • Fluorescence technologies also require "labeling" to link the fluorescence marker to a biologically-relevant material, so that molecular interactions (such as nucleic acid hybridization or ligand/receptor binding) can be detected. Linkage of a fluorescent tag to a biomolecule inevitably increases the complexity of such molecules and can adversely affect probe/target interactions. In addition, fluorescence labeling is expensive, labor intensive and time consuming.
  • experimental reagents containing either radioactive or fluorescence tags often are of limited usefulness (for example, due to the radiochemical half-life of the radioisotope, or due to light sensitivity of the fluorescence label).
  • electronic or electrochemical detection processes are based on interactions between probe molecules on an electrode and target molecules in the detection solution that are detected as alterations in the electrical properties on the electrode.
  • Electronic or electrochemical detection eliminates many of the disadvantages inherent in using radioactive or fluorescent labels to discern molecular interactions. More importantly, electronic or electrochemical detection devices can be made portable, as has been demonstrated in the case of widely available glucose sensors. Electrical and electrochemical detection devices thus provide an alternative molecular detection means that is safe, inexpensive, unobtrusive, and sensitive.
  • biomolecules Electronic or electrochemical detection methods provide an attractive alternative to autoradiography or optical detection for identifying molecular interactions.
  • electrochemical detection of biological molecules has generally been achieved by one of two methods. The first is selective modification at specific sites of a biomolecule (such as a nucleic acid or protein) with redox active moieties such as transition metal complexes. The second approach is intercalation of redox-active moieties, e.g. into duplex DNA strands.
  • a significant disadvantage of the electronic or electrochemical detection devices known in the prior art is that these devices use low-density arrays.
  • Egger et. al. disclosed an apparatus for identifying biomolecular species within a sample substance using an array having a plurality of test sites upon which the sample was applied. Each test site had at least one electrode attached thereto for coupling with a second electrode surrounding the test site to form a capacitor in conjunction with the sample substance.
  • the second electrode was preferably made of a ring located outside the array and also acted to contain the sample solution
  • Egger's array required a large amount of sample solution (i.e., enough to cover the area within the ring) in order for the array to function. More importantly, Egger's array could not be made row and column (x-y) addressable, limiting the density of the test sites in the array and thereby limiting the usefulness of this apparatus.
  • Hollis et al. disclosed an x-y addressable array where test sites were composed of digitated electrodes located on a side bridge that was connected to both the x and y addressable conductive leads.
  • the array of Hollis et al. is not practical to fabricate since the test sites are designed to bridge the x-and-y addressable conductive leads that are on two different planes with an insulating layer in- between.
  • This invention provides an apparatus for electronic biomolecule detection using a column-and-row (x-y) addressable, high-density biochip array and methods of use thereof. Specifically, the apparatus facilitates electronic or electrochemical detection of molecular interactions between probe molecules bound to defined regions of a high-density addressable array and target molecules in a solution that is exposed to the array.
  • the apparatus comprises a multiplicity of individual well structures, each said well further comprising two electrodes that can be individually addressed by applying an electric signal specifically to a particular address (well) in the array.
  • the bottom of the well comprises one electrode surface, while the second electrode surrounds the top of the well.
  • Probe molecules include but are not limited to oligonucleotides, nucleic acids (DNA, RNA, etc), proteins, antibodies and peptides that are immobilized at a specific address comprising a well in the array.
  • Immobilization of such species is accomplished by direct anchoring of the probe molecules on the electrode surface, preferably by attaching the probe molecules onto a supporting matrix on the surface of the electrodes.
  • the immobilized probe molecules are exposed to a solution containing an intended target molecule, for a time and under conditions sufficient for the probe molecules to bind to the target.
  • An electrical signal is then applied to each of the individual well structures comprising the array.
  • a change in the detected electrical signal in the presence of the solution (compared with the electrical signal detected in the absence of the solution) is used to determine whether a binding event between the probe and target has occurred at a particular address in the array.
  • Figure 1 illustrates a schematic representation of a cross-section view of the device platform.
  • Figure 2 illustrates a schematic representation of a top view of the device platform.
  • Figure 3 is a schematic diagram of the row/column configuration of a high-density array useful in the practice of the invention.
  • Figure 4 is a photograph of an x-y addressable array of the invention.
  • Figures 5A, 5B and 5C are masks for depositing electrode and insulating layers in the x-y addressable arrays of the invention.
  • biomolecule is intended to encompass biologically-derived molecules that interact specifically with one another.
  • biomolecules are complementary nucleic acid strands, ligand/receptor, agonist/receptor and antagonist/receptor pairs, antigens and their cognate antibodies, enzyme/substrate and enzyme/inhibitor combinations.
  • the biomolecules of the invention comprise a binding pair, whereby there is a specific interaction between each member of the pair.
  • target one member of the pair is conveniently termed a “target” and the other a “probe.”
  • probe molecules are preferably bound to a solid substrate and "target” molecules comprise a sample to be tested for the presence, amount or concentration of the "target.”
  • Target molecules can be any of these biomolecules, most preferably wherein at least one of the target molecules specifically interacts with one of the probe molecules.
  • the probe molecules are oligonucleotides.
  • Oligonucleotide probes of length 5 to 1000 basepairs (bp), more preferably 5 to 1 OObp and most preferably about 5 to 40bp, can be attached to the attachment medium.
  • Targets include PCR amplicons, genomic DNA, cDNA and synthetic and cellular RNA.
  • probes can be oligonucleotides such as aptamers or other oligonucleotides having well-defined secondary structure that will bind to proteins.
  • peptides, antibodies or antigens can be immobilized to perform binding assays.
  • the present invention provides an apparatus for electronic or electrochemical detection of biomolecules using a row-and-column ("x-y") addressable array having a plurality of addressable sites to which a target sample is applied, and methods of use thereof.
  • Each addressable site comprises at least two electrodes that are connected to two conductive lead lines that can be addressed in a x-y coordination fashion.
  • the addressable site is preferably a well structure as defined herein wherein the bottom of the well comprises the surface of one electrode, and the top of the well comprises the second electrode.
  • each said well structure further comprises at least one additional electrode, preferably a reference electrode, positioned between the top and bottom of the well.
  • the devices of the invention comprise at least two electrodes, and a multiplicity of probe molecules immobilized in proximity to the electrodes, wherein the probe molecules are preferably immobilized at the surface of at least one of the electrodes.
  • Device embodiments of the invention are useful for performing methods for biomolecule detection by either electrochemical or electronic means.
  • electrochemical detection is intended to encompass methods based on oxidation/reduction (redox) processes induced by electron transfer between electrodes, most preferably mediated by an electrochemical reporter group attached to the probe moiety, the target moiety, or both.
  • electrochemical detection is intended to encompass methods that rely on impedance changes (such as resistance, capacitance and inductance) due to differences in electronic state occupancy in the biomolecules in the bound and unbound conformations.
  • An additional advantage of the devices of the invention is that both impedance and electrochemical measurements can be performed in the same assay using the same x-y addressable array to enhance the sensitivity and reduce system "noise" resulting from nonspecific binding of biomolecules.
  • probe arrays comprising nucleic acids
  • electrochemistry it is generally not possible to perform electrochemistry on the probe molecules themselves, since they cannot participate in redox reactions under readily-achievable voltage potentials unless they are linked to an electrochemical reporter group that can participate in such a redox reaction.
  • an impedance measurement of the probe array can be performed in either the presence or absence of such electrochemical reporter groups to monitor the quality of probe attachment at each particular address prior to introduction of the target.
  • electrochemistry can be performed on the molecular complex at or near the redox potential of the electrochemical reporter group where molecules tagged with an electrochemical reporter groups have hybridized to the immobilized probe.
  • This provides an additive signal to be measured that distinguishes background binding from specific binding at each address in the x-y addressable array.
  • This feature of the assay provides an increased assay sensitivity by reducing the baseline (noise or background) signal due to non-specific binding of the target to the probe.
  • This feature is also a unique characteristic of the multielectrode device structure described here and is not found in the prior art.
  • the electrochemical reporter groups comprise a transition metal complex, most preferably containing a transition metal ion that is ruthenium, cobalt, iron or osmium.
  • a transition metal complex most preferably containing a transition metal ion that is ruthenium, cobalt, iron or osmium.
  • the patterned conductive electrodes 5 are fabricated of electrically-conductive metals (including but not limited to transition metals such as aluminum, gold, copper, silver, platinum, chromium, and titanium), transparent conductors (such as indium-tin-oxide and zinc oxide), conductive plastics (such as polymers like polythiophenes, polyanilines, polypyrroles, and metal impregnated polymers), or conductive carbon (such as graphite).
  • electrically-conductive metals including but not limited to transition metals such as aluminum, gold, copper, silver, platinum, chromium, and titanium
  • transparent conductors such as indium-tin-oxide and zinc oxide
  • conductive plastics such as polymers like polythiophenes, polyanilines, polypyrroles, and metal impregnated polymers
  • conductive carbon such as graphite
  • Non-limiting examples of methods for producing solid substrates comprising the device platforms of the invention include but are not limited to thermal evaporation, wire bonding, metallization (evaporation, plating, sputtering over a shadow mask), dielectric deposition (by plasma, chemical vapor deposition or sputtering ), wet or dry chemical etching, reactive ion etching, or liftoff after the desired pattern has been defined using conventional photolithography.
  • An optional layer of conductive metal 3 is placed over the insulative dielectric material 4. This layer constitutes a reference electrode.
  • the conductive metal layer 3 is silver, which is then advantageously converted to silver /silver chloride at a later stage in manufacturing.
  • a second layer of insulative dielectric material 2 is then placed on top of the conductive electrode layer 3.
  • a continuous dielectric layer 2 comprising layers 2 and 4 as set forth herein are deposited.
  • the second layer of insulative dielectric material 2 is optionally made of the same materials as the insulative layer 4.
  • Patterned conductive electrodes 1 constructed on top of the second layer of insulative dielectric material 2 constitute the final layer of each addressable site in the device 9.
  • Well structures 7 are fabricated from this device by conventional photolithography or laser drilling methods used in the semiconductor industry for PCB manufacturing. These wells can have rectangular, circular, trapezoidal or other polygonal openings. Additionally, the well walls may be either straight or curved, and may have an arbitrary angle with respect to the bottom electrode 5. An optional center electrode can alternatively protrude into the well area, as shown in Figure 3.
  • Figure 2 illustrates a schematic representation of a top view of the apparatus of the invention.
  • the conductive electrodes 1 are preferred to be oriented in a direction orthogonal to the patterned conductive electrodes 5, generating row (i.e., patterned electrodes 5) and column (i.e., conductive electrodes 1) addressable high-density electronic or electrochemical mini-cells (i.e., well structures 7) with optional reference electrodes built in-between.
  • the well structure is preferably produced wherein the bottom of the well structure comprises the top of electrode 5 surface, while the top of the well structure is surrounded by the second electrode 1.
  • the proposed device 9 can be used as an x-y addressable, high-density biochip array when biological probes 10 are immobilized on the patterned electrodes 5 inside each well structure 7.
  • the apparatus is capable of detecting changes in the electrical properties of the probes 10 in each well structure arising from the interaction of the probes 10 with target molecules 11.
  • the inventive apparatus is useful for single species detection, where only a few test wells (low density) are required, the advantages of the invention are more pronounced in a high density array where hundreds, thousands, or millions of test wells are integrated in one array.
  • the probe molecules may be oligonucleotides, nucleic acids (such as DNA or RNA), proteins, peptides, antibodies or small molecules such as ligands, wherein probe molecules are chemically modified to contain anchoring groups that permit immobilization.
  • probe molecules can be efficiently immobilized on the electrode surface through an intermediate species, termed a "spacer.”
  • the surface of the electrodes 5 is covered with a layer of polymer matrix.
  • probe molecules are attached onto a supporting matrix on the surface of the electrodes using the functional chemistry mentioned above.
  • the polymer matrix is preferably selected to be polypyrrole, polythiophene, polyaniline, polyacrylamide, agarose gel, polyethylene glycol, cellular, sol gels, dendrimers, metallic nanoparticles, carbon nanotubes, and their copolymers.
  • porous matrix such as polyacrylamide, agarose, or sol gels are preferred.
  • Electronic or electrochemical detection of molecular interactions between probe and target molecules is achieved by devices having the structure, for example, as depicted in Figure 1.
  • the electric or/and electrochemical methods used to interrogating the biomolecule targets may be selected from, but are not limited to, AC impedance, cyclic voltammetry (CN), pulse voltammetry, square wave voltammetry, AC voltammetry (ACN), hydrodynamic modulation voltammetry, potential step method, potentiometric measurements, amperometric measurements, current step method, and combinations thereof.
  • an active driving circuit such as the one used in an active matrix liquid crystal display device can be built underneath or nearby each test well site to replace the electronic column and row drivers for x-y addressing such as the one used in the passive matrix liquid crystal display device.
  • a high-density, x-y addressable probe array is exposed to an electrolyte solution containing a target molecule for a time and under conditions sufficient for the target to bind to a probe present in at least one of the particular addresses of the column-and-row addressable array.
  • a voltage potential or other electric signal is applied to the each of the electrodes comprising each of the addressable sites through the x-y addressable column and row electrodes. Changes in the electrical properties or electrical signals from a particular electrode at a particular site in the x-y addressable array arising from interactions between probe molecules on the electrode and target molecules in the solution are detected to determine the presence and concentration of the target molecules in the solution.
  • electrical cross-talk between electrodes is reduced or eliminated in the x-y addressable array during target interrogation with an external electrical source.
  • the electrodes at the top of the wells are covered with an array of microfluidic channels. These channels are designed to be independently isolated from each other, with each having its own isolatable liquid inlet and outlet port. In addition to functioning as an electrical isolator, the channels also act as containers or reaction chambers for liquid during probe-target hybridization, enzymatic reactions and target interrogation with the external electrical source.
  • the microfluidic channels can be replaced by a single chamber that covers all the test sites with
  • Electrolyte solutions useful in the apparatus and methods of the invention include any electrolyte solution at physiologically-relevant ionic strength (equivalent to about 0.15M NaCl) and neutral pH.
  • Nonlimiting examples of electrolyte solutions useful with the apparatus and methods of the invention include but are not limited to phosphate buffered saline, HEPES buffered solutions, and sodium bicarbonate buffered solutions.
  • the electrolyte solution comprises metal cations or polymerized cations that are ion conductive and capable of reacting with probes or probe-target complexes.
  • the Examples, which follow, are illustrative of specific embodiments of the invention, and various uses thereof. They are set forth for explanatory purposes only, and are not to be taken as limiting the invention.
  • a linear test microarray with four wells was fabricated on a 3" inch silicon wafer as follows. A photograph of the array is shown in Figure 4.
  • the linear test array was fabricated by conventional photolithography in a class 100 clean room and fabrication was performed using three layers of masks as shown in Masks 12 ( Figure 5 A), 14 ( Figure 5B) and 16 ( Figure 5C).
  • a three inch silicon wafer was cleaned using a solution of NH OH:H 2 0 (1 : 10 v/v), rinsed with de-ionized water, and then dried using a stream of nitrogen at room temperature.
  • 2000A Si0 2 was deposited by conventional chemical vapor deposition technique.
  • the array was then prepared sequentially as follows.
  • the PR was hardbaked and developed.
  • the following metals were deposited sequentially by evaporation: Ti (to a thickness of 1.0 Angstrom), Au (to a thickness of 21,000 Angstrom), and Ti (to a thickness of 500 Angstrom). After evaporative deposition of these metal layers, a liftoff protocol was used to produce the bottom patterned electrode.
  • the wafer was coated with a thick (8 micron) layer of PR, as described above.
  • Mask 14 Figure 5B to protect the portion of the substrate that forms the top electrode, the surface was exposed to an ultraviolet light source using a wavelength of 365 nm and an intensity of 6 mW/cm 3 .
  • the PR was hardbaked and developed as described above
  • the following metals were deposited sequentially by evaporation: Ti (to a thickness of 1.0 Angstrom) and Au (to a thickness of 21,000 Angstrom). After evaporative deposition of these metal layers, a liftoff protocol was used to produce the top patterned electrode, as described above.
  • the surface was exposed to an ultraviolet light source using a wavelength of 365 nm and an intensity of 6 mW/cm 3 .
  • the PR was hardbaked and developed as described above.
  • the wafer was then subjected to buffer oxide etching solution (4: 1) until each well opening was cleared.
  • the PR was removed by placing in a Branson 4000 Sonicator.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electrochemistry (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne un procédé et un dispositif comprenant une plate-forme destinée à une matrice de biopuces, haute densité, adressable par colonnes et rangées. On peut utiliser ce dispositif en tant que matrice de biopuces haute densité, dans la détection électronique ou électrochimique d'interactions moléculaires entre des molécules sondes liées à des régions déterminées de la matrice, et des molécules cibles exposées à la matrice.
EP00984476A 1999-12-15 2000-12-14 Matrice de biopuces, haute densite, adressable par colonnes et rangees Withdrawn EP1251955A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46450099A 1999-12-15 1999-12-15
US464500 1999-12-15
PCT/US2000/034222 WO2001043870A2 (fr) 1999-12-15 2000-12-14 Matrice de biopuces, haute densite, adressable par colonnes et rangees

Publications (1)

Publication Number Publication Date
EP1251955A2 true EP1251955A2 (fr) 2002-10-30

Family

ID=23844193

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00984476A Withdrawn EP1251955A2 (fr) 1999-12-15 2000-12-14 Matrice de biopuces, haute densite, adressable par colonnes et rangees

Country Status (5)

Country Link
EP (1) EP1251955A2 (fr)
JP (1) JP2003517149A (fr)
AU (1) AU2108901A (fr)
CA (1) CA2393766A1 (fr)
WO (1) WO2001043870A2 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6824669B1 (en) 2000-02-17 2004-11-30 Motorola, Inc. Protein and peptide sensors using electrical detection methods
US6824974B2 (en) 2001-06-11 2004-11-30 Genorx, Inc. Electronic detection of biological molecules using thin layers
CA2450109A1 (fr) * 2001-06-11 2003-05-22 Genorx, Inc. Detection electronique de molecules biologiques au moyen de fines couches
GB2377026A (en) * 2001-06-29 2002-12-31 Imp College Innovations Ltd Electrically addressable electrochemical cell array
DE10145700A1 (de) * 2001-09-17 2003-04-10 Infineon Technologies Ag Biochip-Anordnung, Sensor-Anordnung und Verfahren zum Betreiben einer Biochip-Anordnung
US7074519B2 (en) * 2001-10-26 2006-07-11 The Regents Of The University Of California Molehole embedded 3-D crossbar architecture used in electrochemical molecular memory device
DE10211358B4 (de) * 2002-03-14 2006-10-26 Siemens Ag Vertikal-Impedanz-Sensor-Anordnung und Verfahren zum Herstellen einer Vertikal-Impedanz-Sensor-Anordnung
FR2839783B1 (fr) * 2002-05-17 2004-08-06 Apibio Nouvelle disposition des sites de liaison d'une biopuce
FR2840072B1 (fr) * 2002-05-24 2004-08-06 Apibio Biopuce presentant une organisation amelioree
DE10228125A1 (de) * 2002-06-24 2004-01-22 Infineon Technologies Ag Biosensor-Array und Verfahren zum Betreiben eines Biosensor-Arrays
DE50305588D1 (de) * 2002-06-24 2006-12-14 Siemens Ag Biosensor-array und verfahren zum betreiben eines biosensor-arrays
DE10228124A1 (de) * 2002-06-24 2004-01-29 Infineon Technologies Ag Biosensor-Array und Verfahren zum Betreiben eines Biosensor-Arrays
US6962822B2 (en) 2002-08-07 2005-11-08 International Business Machines Corporation Discrete nano-textured structures in biomolecular arrays, and method of use
JP4426968B2 (ja) * 2002-09-17 2010-03-03 オリンパス株式会社 基体上での複数成分間の反応によりターゲット物質を検出するために基体表面に液状反応成分を配置する方法および装置、並びにこの方法に使用するための物品
DE10257604A1 (de) * 2002-12-09 2004-07-22 Axaron Bioscience Ag Kapazitiver Nachweis von gebundenen Molekülen
WO2005016115A2 (fr) 2003-01-23 2005-02-24 Montana State University Biocapteurs faisant intervenir des ligands immobilises sur des dendrimeres et utilisation de ceux-ci
GB2398751A (en) 2003-02-28 2004-09-01 Univ Surrey A dielectrophoretic separation device
JP2004298783A (ja) * 2003-03-31 2004-10-28 Kitakyushu Foundation For The Advancement Of Industry Science & Technology 化学物質分離膜及びその製造方法、並びに化学物質の検出方法及び化学物質検出装置
US7399400B2 (en) 2003-09-30 2008-07-15 Nano-Proprietary, Inc. Nanobiosensor and carbon nanotube thin film transistors
JP4891772B2 (ja) 2003-10-08 2012-03-07 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ バルク超音波センサ
US20080070803A1 (en) * 2003-10-15 2008-03-20 Egeland Ryan D Electrochemical Treatment Of Substrates
US7390622B2 (en) * 2003-10-16 2008-06-24 Hai Kang Life Corporation Limited Apparatus and methods for detecting nucleic acid in biological samples
KR101165860B1 (ko) 2003-10-16 2012-07-13 하이 캉 라이프 코포레이션 리미티드 생물학적 샘플에서 핵산을 검출하는 장치 및 방법
US20050244811A1 (en) * 2003-12-15 2005-11-03 Nano-Proprietary, Inc. Matrix array nanobiosensor
DE102004031672A1 (de) 2004-06-30 2006-01-19 Infineon Technologies Ag Planar-Sensor-Anordnung, Sensor-Array und Verfahren zum Herstellen einer Planar-Sensor-Anordnung
JP5041680B2 (ja) * 2005-06-17 2012-10-03 株式会社ハイペップ研究所 バイオチップ用基板及びバイオチップ
JP4635258B2 (ja) * 2006-03-02 2011-02-23 独立行政法人産業技術総合研究所 バイオセンサー
US8105469B2 (en) 2006-03-17 2012-01-31 Andrew John Whitehead Microelectrode array
JP2010509577A (ja) * 2006-11-09 2010-03-25 ナノアイデント テクノロジーズ アクチェンゲゼルシャフト 薄膜光センサを備えるタイタプレート
AT505688A1 (de) 2007-09-13 2009-03-15 Nanoident Technologies Ag Sensormatrix aus halbleiterbauteilen
JP5176235B2 (ja) * 2008-07-03 2013-04-03 国立大学法人東北大学 電気化学測定装置
GB0821810D0 (en) * 2008-11-28 2009-01-07 Nanoflex Ltd Electrode assembly
DE102011010767A1 (de) * 2011-02-09 2012-08-09 Forschungszentrum Jülich GmbH Verfahren zur Herstellung einer Vorrichtung zum Nachweis eines Analyten sowie Vorrichtung und deren Verwendung
EP2492674A1 (fr) 2011-02-28 2012-08-29 Lexogen GmbH Réseaux de biocapteurs formé par jonctions d'électrodes fonctionnalisées
WO2013119845A1 (fr) 2012-02-07 2013-08-15 Vibrant Holdings, Llc Substrats, réseaux de peptides et procédés
US10006909B2 (en) 2012-09-28 2018-06-26 Vibrant Holdings, Llc Methods, systems, and arrays for biomolecular analysis
DE102013207779A1 (de) * 2012-10-23 2014-05-15 Heraeus Precious Metals Gmbh & Co. Kg Multischichtaufbau mit alternierenden leitenden und nicht leitenden Schichten
US9523642B2 (en) * 2012-11-09 2016-12-20 Taiwan Semiconductor Manufacturing Company, Ltd. Integrated electro-microfluidic probe card, system and method for using the same
US10286376B2 (en) 2012-11-14 2019-05-14 Vibrant Holdings, Llc Substrates, systems, and methods for array synthesis and biomolecular analysis
EP3702782B1 (fr) * 2013-02-15 2022-04-06 Vibrant Holdings, LLC Procédés et compositions de détection de l'électrochimioluminescence amplifiée
CN103627788A (zh) * 2013-08-21 2014-03-12 中山大学达安基因股份有限公司 一种电化学基因传感器生物芯片的制备方法
US9498142B2 (en) 2014-07-03 2016-11-22 Heraeus Deutschland GmbH & Co. KG Multi-layered structure and method
CN107532986B (zh) * 2014-12-23 2021-03-05 贺利氏耐克森索斯有限责任公司 用于检测导电和/或可极化粒子的传感器及其调整方法
US20180024023A1 (en) * 2015-01-29 2018-01-25 Aram Corporation Liquid sensor
JP6116080B1 (ja) * 2016-04-26 2017-04-19 日本航空電子工業株式会社 電気化学測定方法、電気化学測定装置及びトランスデューサ
US10538808B2 (en) 2017-05-26 2020-01-21 Vibrant Holdings, Llc Photoactive compounds and methods for biomolecule detection and sequencing
KR102423723B1 (ko) * 2020-08-27 2022-07-21 성균관대학교산학협력단 플라즈모닉 우물 기반 핵산 검출장치 및 롤투롤 공정을 이용한 이의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2238003C (fr) * 1995-12-01 2005-02-22 Innogenetics N.V. Systeme de detection par mesure de l'impedance et procede pour le fabriquer
US5727977A (en) * 1996-03-04 1998-03-17 Motorola, Inc. Process for manufacturing a field-emission device
NZ504675A (en) * 1997-08-08 2003-12-19 Cyrano Sciences Inc Techniques and systems for analyte detection
GB9810568D0 (en) * 1998-05-18 1998-07-15 Imco 1097 Limited Electrode system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0143870A3 *

Also Published As

Publication number Publication date
WO2001043870A2 (fr) 2001-06-21
CA2393766A1 (fr) 2001-06-21
WO2001043870A3 (fr) 2002-02-21
AU2108901A (en) 2001-06-25
JP2003517149A (ja) 2003-05-20

Similar Documents

Publication Publication Date Title
EP1251955A2 (fr) Matrice de biopuces, haute densite, adressable par colonnes et rangees
US6602400B1 (en) Method for enhanced bio-conjugation events
JP4562914B2 (ja) 化学的または生物学的分析マルチポイントマイクロシステム
Sassolas et al. DNA biosensors and microarrays
EP2681545B1 (fr) Réseau de biocapteurs formé par jonctions d'électrodes fonctionnalisées
EP1075656B1 (fr) Detection d'une cible dans un echantillon
US20020028441A1 (en) Detection of molecules and molecule complexes
US7488607B2 (en) Electronically readable microarray with electronic addressing function
E Ferapontova Electrochemical indicators for DNA electroanalysis
WO1999067628A1 (fr) Ensemble multicapteur de reconnaissance electrochimique de sequences nucleotidiques, et procedes y relatifs
AU2907201A (en) Methods and compositions relating to electrical detection of nucleic acid reactions
CA2394126A1 (fr) Procede et dispositif de detection et de quantification de biomolecules
US20040157263A1 (en) Method for impedimetric detection of one or more analytes in a sample, and device for use therin
JP2004524534A (ja) 電極構造を用いた巨大生体高分子の検出方法
Kékedy-Nagy et al. Sequence-specific electron transfer mediated by DNA duplexes attached to gold through the alkanethiol linker
WO2000077523A1 (fr) Biocapteurs utilisant des polymeres conjugues a charge neutre
US8097134B2 (en) Addressable chem/bio chip array
Gajovic-Eichelmann et al. Directed immobilization of nucleic acids at ultramicroelectrodes using a novel electro-deposited polymer
JP2003090815A (ja) 遺伝子の電気化学的検出方法と核酸チップ
US20020051975A1 (en) Reporterless genosensors using electrical detection methods
US20030175737A1 (en) Quantifying target molecules contained in a liquid
US20050069905A1 (en) Detection of molecular binding events
CA2471339A1 (fr) Methode et dispositif pour la detection electrique quantitative d'analytes
WONG Recent trends in DNA biosensing technologies
KR100994752B1 (ko) 디엔에이 하이브리드형성의 전기적 검출방법과 이를 위한디엔에이칩 및 그 제조방법

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020711

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20031217

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040428